Geriatric syndrome Flashcards

1
Q

Four types of urinary incontinence

A

Stress
Urge
Overflow
Functional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cause of stress UI

A
  • Weak pelvic floor muscles (e.g. from childbirth, pregnancy, menopause)
  • Bladder outlet/urethral sphincter weakness
  • Post-urologic surgery (e.g. prostatectomy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cause of urge UI

A
  • Detrusor overactivity
  • Local genitourinary conditions (e.g. tumours, diverticula)
  • CNS disorders (e.g. stroke, dementia, PD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cause of overflow UI

A
  • Obstruction by prostate, strictures
  • Acontractile bladder associated with DM or spinal cord injury
  • Neurogenic (e.g. MS)
  • Medication-induced
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Causes of functional UI

A
  • Severe dementia
  • Psychological conditions
  • Pain and immobility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Transient causes of UI

A

Delirium
Infection
Atrophic vaginitis
Pharmaceuticals
Psychological
Excessive urine output (e.g. from hyperglycaemia)
Reduced mobility / reversible urinary retention (e.g. drug-induced)
Stool impaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Drugs that can contribute to UI

A
  • Antihistamines
  • Decongestants
  • Benzos
  • Opioids
  • Anticholinergics/antimuscarinics/cholinestrase inhibitors
  • Spamolytics
  • ACE inhibitors
  • Alpha blockers
  • Alpha agonists
  • Calcium channel blockers
  • Antiarrhythmics
  • Diuretics
  • Antidepressants (SNRI, TCA)
  • Gabapentin/pregabalin
  • Muscle relaxants
  • PO Estrogens
  • Beta-3 agonists
  • Thiazolinediones
  • Alcohol/caffeine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Management of stress UI

A
  • Kegel’s exercise
  • Topical estrogens
  • Duloxetine
  • Surgery/devices
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Management of urge UI

A
  • Kegel’s exercise
  • Treat BPH
  • Topical estrogens
  • Beta-3 agonist
  • Antimuscarinics
  • Bolutinum toxin injections
  • Sacral nerve stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Management of overflow UI

A

Bladder obstruction
- Treat BPH/strictures accordingly
- Treat uterine prolapse in women
- Bowel habit optimisation

Bladder under activity
- Bethanechol
- Clean intermittent catherisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Fall risk assessment

A
  • History of falls
  • Meds
  • Gait, balance and mobility
  • Visual acuity
  • Other neuro conditions
  • Muscle strength
  • Heart rate and rhythm
  • Postural hypotension
  • Feet and footware
  • Environmental hazards
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

STOPPFall drugs

A
  • Orthostatic drugs (alpha blockers, central antihypertensives, vasodilators, diuretics)
  • Opioids
  • Psychotropics (antidepressants, antipsychotics, benzos, Z-hypnotics)
  • Anticonvulsants
  • Anticholinergics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dangerous etiologies of dizziness

A
  • Stroke/TIA
  • STEMI/arrhythmias
  • Active bleeding and hypovolemia
  • Tumors
  • Brain infections
  • Other infections (pneumonia)
  • Meds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

4ATs

A

Used for detection of delirium
- Alertness
- Abbreviated mental test 4 (DOB, Age, Place, current year)
- Attention (counting down months, simple calculations)
- Acuity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Causes of delirium

A

Infections
Withdrawals
Acute metabolic disorders
Trauma
CNS pathology
Hypoxia
Deficiencies
Endocrinopathies
Acute vascular
Toxins/substances
Heavy metals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Management of acute agitation

A
  • SC/IM/PO Haloperidol 0.3-1 mg BD, max 5 mg/day
  • PO Quetiapine 6.25-12.5 mg BD, max 100 mg/day
  • PO Olanzapine 1.25-2.5 mg, max 10 mg/day
  • PO/IV/SC Lorazepam 0.5-1 mg
17
Q

Monitoring for withdrawing benzodiazepines

A

Anxiety, insomnia, agitation
Possibly delirium, seizures, confusion

18
Q

Monitoring for withdrawing antipsychotics

A

Recurrence of psychotic symptoms
Possibly insomnia

19
Q

Monitoring for withdrawing opioids

A

Recurrence of pain
Possibly MSK symptoms, restlessness, GI symptoms, anxiety, insomnia, diaphoresis, anger, chills

20
Q

Monitoring for withdrawing antidepressants

A

Recurrence of depression, flu-like symptoms, anxiety, irritability, insomnia
Possibly headache, malaise, GI symptoms

21
Q

Monitoring for withdrawing antiepileptics

A

Seizures
Possibly anxiety, restlessness, insomnia, headache

22
Q

Monitoring for withdrawing diuretics

A

Fluid overload, hypertension

23
Q

Monitoring for withdrawing alpha blockers

A

Hypertension
Possibly headache, palpitations

24
Q

Monitoring for withdrawing vasodilators

25
Monitoring for withdrawing antihistamines
Return of symptoms Possibly anxiety, insomnia
26
DRP screening
Indication Efficacy Drug-disease interaction Drug-drug interaction Dose Dosing instructions Duplication Duration Cost-effectiveness
27
What does the MAI not have?
- ADR - Failure to receive treatment - Untreated indications
28
Risk factors for delirium
Age at least 65 y.o. Cognitive impairment (current or previous) Current hip fracture Severe illness
29
Comprehensive geriatric assessment
Functional status (BADL, IADL) Medical review Cognitive/mood assessment Medication & nutrition optimisation Social resources
30
ABCDEF framework
Accurate diagnosis Behavioural & psychological symptoms Caregiver stress Drugs and disabilities End of life discussion Financial support
31
BADL
Dressing Eating Ambulating Toileting Hygiene
32
IADL
Shopping Housekeeping Accounting Food preparation Taking medications Telephone Transport
33
Non-pharmacological measures for urinary incontinence
Kegel's exercise Weight loss Reduced urinary irritants Normalise bowel habits Timed voiding Incontinence products